HOME >> BIOLOGY >> NEWS
Christopher Walsh wins 2004 Promega Biotechnology Research Award

WASHINGTON, DC--APRIL 23, 2004--Christopher T. Walsh, Ph.D., Hamilton Kuhn Professor of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Cambridge, Massachusetts, will receive the 2004 Promega Biotechnology Research Award from the American Society for Microbiology (ASM). Supported by Promega Corporation, the award honors Walsh for his landmark contributions to the field of microbial biochemistry, particularly for his findings on natural product biosynthesis and biotechnology. At the ASM General Meeting, Walsh will deliver the Promega Award Lecture, "Vancomycin: Action, Origin, Resistance; The Evolving Story of a Natural Product Antibiotic."

Walsh's invaluable achievements include uncovering how disease-causing enterococci can make themselves resistant to the antibiotic vancomycin, how antibiotics such as gramicidin and tyrocidine are naturally synthesized by bacteria, and how bacteria use iron-binding substances called siderophores to control important aspects of microbial virulence.

Each of these projects has vital implications for future drug research. For example, Walsh's research on tyrocidine, a naturally produced antibiotic, has led to the construction of new manufactured compounds, which are as strong as naturally produced tyrocidine, while targeting infections more selectively. His work on vancomycin resistance, which showed how pathogenic enterococci eliminate a key hydrogen bond in their cell walls to alter the effectiveness of this drug, has also directly affected current antibiotic development. Walsh's research has had other, far-reaching implications as well: his attention to vancomycin resistance heightened awareness of this phenomenon long before microbial resistance to antibiotic drugs became an issue of grave concern in health care.

Walsh earned his A.B. in biology at Harvard University, Cambridge, Massachusetts, and his Ph.D. in life sciences at the Rockefeller University, New Yor
'"/>

Contact: Barbara Hyde
bhyde@asmusa.org
202-942-9206
American Society for Microbiology
30-Apr-2004


Page: 1 2

Related biology news :

1. Astrobiologist and national security expert Christopher Chyba named 2001 MacArthur
2. UCSD-Salk Institute awards presented to Christopher Reeve, Dr. Donald Seldin, Genentech, Inc. and Dr. Dennis Slamon
3. Nanosphere announces genetic detection advance in Nature Biotechnology
4. Leroy Hood to receive 2004 Biotechnology Heritage Award
5. Advancing Biotechnology Breakthroughs
6. Bacteriophage genomics approach to antimicrobial drug discovery published in Nature Biotechnology
7. Chemical Heritage Foundation and BIO give Biotechnology Heritage Award to William Rutter
8. Biotechnology taught as a tool for teaching
9. CHF and BIO to present Biotechnology Heritage Award to William J. Rutter
10. When Media, Science and Public Policy Collide: The Case of Food and Biotechnology
11. Biotechnology to protect soldiers of the future, report says

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/1/2020)... ... July 01, 2020 , ... Cure Glioblastoma, a registered 501(c)(3) ... and aggressive adult brain cancer—announced today the appointments of its first Senior Fellows: ... supporting the organization’s initiatives and overall vision. , "Senior Fellows are more than ...
(Date:6/25/2020)... , ... June 24, 2020 , ... ... enterprise software and software-driven clinical data services that accelerate drug development, is collaborating ... selinexor, an XPO1 inhibitor, in hospitalized patients with severe COVID-19. This is the ...
(Date:6/23/2020)... ... June 22, 2020 , ... The field of quantitation of large ... (LBA) have dominated this area. However, the use of mass spectrometry in this field ... necessitates the question “How do you choose which approach to use (LBA or MS)?” ...
Breaking Biology News(10 mins):
(Date:7/10/2020)... ... 09, 2020 , ... In most research using the zebrafish ... formation in zebrafish embryos, maintaining optical transparency to facilitate microscopic imaging. Over the ... using the zebrafish model to investigate the causes of leukaemia and its relationship ...
(Date:7/7/2020)... ... 2020 , ... R3 International is now offering stem cell therapy for Alzheimers ... Depending on the patient's condition, treatment may be offered IV, intrathecal or with a ... of Alzheimers dementia, and the incidence continues to increase as individuals live longer. There ...
(Date:7/1/2020)... ... June 29, 2020 , ... ... date growth of 40% in 2020, despite many obstacles created as a result ... to increase revenue for its partnered medical practices and medical manufacturers by expanding ...
(Date:7/1/2020)... ... June 30, 2020 , ... ... insights, today announced that the launch of a new clinical diagnostics ... about the tumor microenvironment (TME). , “Flagship’s TissueInsight is a service that ...
Breaking Biology Technology:
Cached News: